Germany-based herbal medicines specialist Schwabe Group is tapping into Europe’s fast-growing dietary supplements market by acquiring a controlling stake in local player Braineffect.
Having first taken a minority stake in Berlin’s Braineffect in 2020, Schwabe now holds two-thirds of the firm’s shares, with a medium-term ambition to take full control of a business “with an
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?